Antibe Therapeutics Inc. (ATE.TO) TSX

0.30

+0.035(+13.46%)

Updated at April 08, 2024 03:59PM

Currency In CAD

Valuation

Market Cap31.37M
Enterprise Value24.62M
P/E Ratio-0.79
PEG Ratio-0.01
Price/Sales Ratio0
Price/Book Ratio0.38
Enterprise/Revenue0
Enterprise/EBITDA-0.46

Fiscal Year

Fiscal YearMarch 31, 2023
Most Recent QuarterDecember 31, 2023

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.28
Return On Equity-0.4

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-19.19M
Net Income-19.48M
Diluted EPS-0.37

Balance Sheet

Total Cash24.91M
Total Cash/Share0.74
Total Debt0
Total Debt/Equity0
Current Ratio15.03
Book Value Per Share0.77

Price History

52-Week Change-45.37
52-Week High1.23
52-Week Low0.15
Moving Average 50 Days0.7
Moving Average 200 Days0.66

Statistics

Average Volume139,875
Shares Outstanding53.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateDecember 01, 2020